Cargando…

Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers

[Image: see text] Despite preclinical evidence for psychedelic-induced neuroplasticity, confirmation in humans is grossly lacking. Given the increased interest in using low doses of psychedelics for psychiatric indications and the importance of neuroplasticity in the therapeutic response, this place...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hutten, Nadia R. P. W., Mason, Natasha L., Dolder, Patrick C., Theunissen, Eef L., Holze, Friederike, Liechti, Matthias E., Varghese, Nimmy, Eckert, Anne, Feilding, Amanda, Ramaekers, Johannes G., Kuypers, Kim P. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033605/ https://www.ncbi.nlm.nih.gov/pubmed/33860175 http://dx.doi.org/10.1021/acsptsci.0c00099

Ejemplares similares

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers
por: Ramaekers, Johannes G, et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants
por: Holze, Friederike, et al.
Publicado: (2020)

Role of the 5-HT(2A) Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin
por: Holze, Friederike, et al.
Publicado: (2021)

Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2019)

Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants
por: Becker, Anna M, et al.
Publicado: (2022)

Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants
por: Straumann, Isabelle, et al.
Publicado: (2023)

Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis
por: Vizeli, Patrick, et al.
Publicado: (2021)

Safety Profile and Neurocognitive Function Following Acute 4-Fluoroamphetamine (4-FA) Administration in Humans
por: de Sousa Fernandes Perna, Elizabeth B., et al.
Publicado: (2018)

Neurocognition and Subjective Experience Following Acute Doses of the Synthetic Cannabinoid JWH-018: Responders Versus Nonresponders
por: Theunissen, Eef L., et al.
Publicado: (2019)

Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies
por: Kuypers, Kim PC, et al.
Publicado: (2017)

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2020)

Safety pharmacology of acute LSD administration in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2021)

Motives and Side-Effects of Microdosing With Psychedelics Among Users
por: Hutten, Nadia R P W, et al.
Publicado: (2019)

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers
por: Hutten, Nadia R. P. W., et al.
Publicado: (2019)

A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence
por: Theunissen, Eef Lien, et al.
Publicado: (2022)

Alterations of consciousness and mystical-type experiences after acute LSD in humans
por: Liechti, Matthias E., et al.
Publicado: (2016)

Drug liking and wanting, not impulsive action or reflection is increased by 4-fluoroamphetamine
por: Kuypers, K. P. C., et al.
Publicado: (2018)

Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis
por: Theunissen, Eef L., et al.
Publicado: (2021)

Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans
por: Dolder, Patrick C., et al.
Publicado: (2015)

Altered network hub connectivity after acute LSD administration
por: Müller, Felix, et al.
Publicado: (2018)

A single dose of cocaine enhances prospective memory performance
por: Hutten, Nadia RPW, et al.
Publicado: (2018)

LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
por: Dolder, Patrick C, et al.
Publicado: (2016)

Increased thalamic resting‐state connectivity as a core driver of LSD‐induced hallucinations
por: Müller, F., et al.
Publicado: (2017)

Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants
por: Müller, Felix, et al.
Publicado: (2022)

Cannabis Use and Neuroadaptation: A Call for Δ(9)-Tetrahydrocannabinol Challenge Studies
por: Ramaekers, Johannes G., et al.
Publicado: (2022)

Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects
por: Mueller, F, et al.
Publicado: (2017)

Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users
por: Mason, Natasha L., et al.
Publicado: (2019)

OR17-01 Novel Provocation Test With MDMA (‘Ecstasy’) Reveals Oxytocin Deficiency As A New Pituitary Entity In Patients With Central Diabetes Insipidus - A Randomized Placebo-Controlled Trial
por: Atila, Cihan, et al.
Publicado: (2023)

Treatment of a Complex Personality Disorder Using Repeated Doses of LSD—A Case Report on Significant Improvements in the Absence of Acute Drug Effects
por: Müller, Felix, et al.
Publicado: (2020)

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects
por: Becker, Anna M., et al.
Publicado: (2021)

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity
por: Bedford, Peter, et al.
Publicado: (2023)

Effects of Acute MDMA Intoxication on Mood and Impulsivity: Role of the 5-HT(2) and 5-HT(1) Receptors
por: van Wel, Janelle H. P., et al.
Publicado: (2012)

Interplay between stress, sleep, and BDNF in a high-risk sample of young adults
por: Varghese, Nimmy, et al.
Publicado: (2023)

Modern Clinical Research on LSD
por: Liechti, Matthias E
Publicado: (2017)

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
por: Ley, Laura, et al.
Publicado: (2023)

MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens
por: Müller, Felix, et al.
Publicado: (2020)

A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
por: Prevete, Elisabeth, et al.
Publicado: (2021)

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
por: Mason, N. L., et al.
Publicado: (2020)

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2022)

Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis
por: Hutten, Nadia R. P. W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e1mvt10a4mgc06r1b588holqg9